Advanced

Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod.

Svensson, Leif D; Sennbro, Carl Johan LU ; Svanström, Camilla and Hansson, Gunnar P (2015) In Bioanalysis 7(2). p.179-191
Abstract
Tasquinimod is an orally active anticancer drug in late clinical development. Here we describe the development and validation of a bioanalytical method based upon dried blood spot analysis in combination with LCMS/MS and stable isotope dilution.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Bioanalysis
volume
7
issue
2
pages
179 - 191
publisher
Future Science
external identifiers
  • pmid:25587835
  • wos:000354284100005
  • scopus:84921353309
ISSN
1757-6180
DOI
10.4155/bio.14.259
language
English
LU publication?
yes
id
fbdfbff2-0d22-4364-922b-f36ed38ddccb (old id 5040391)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25587835?dopt=Abstract
date added to LUP
2015-02-03 17:31:38
date last changed
2017-01-01 04:13:03
@article{fbdfbff2-0d22-4364-922b-f36ed38ddccb,
  abstract     = {Tasquinimod is an orally active anticancer drug in late clinical development. Here we describe the development and validation of a bioanalytical method based upon dried blood spot analysis in combination with LCMS/MS and stable isotope dilution.},
  author       = {Svensson, Leif D and Sennbro, Carl Johan and Svanström, Camilla and Hansson, Gunnar P},
  issn         = {1757-6180},
  language     = {eng},
  number       = {2},
  pages        = {179--191},
  publisher    = {Future Science},
  series       = {Bioanalysis},
  title        = {Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod.},
  url          = {http://dx.doi.org/10.4155/bio.14.259},
  volume       = {7},
  year         = {2015},
}